MEDICAL RECOMMENDATIONS

Management of the patent ductus arteriosus in preterm infants

Canadian Paediatric SocietyPediatrics2022Official publication

ASEM documentary overview

Official Canadian Paediatric Society document (2022) on “Management of the patent ductus arteriosus in preterm infants”. Management of the patent ductus arteriosus (PDA) is one of the most contentious topics in the care of preterm infants. PDA management can be broadly divided into prophylactic and symptomatic therapy. Prophylaxis with intravenous indomethacin in extremely low birth weight infants may reduce severe intraventricular hemorrhage. Echocardiography should be routinely used to confirm the presence of a PDA before considering.

This overview helps you identify the document. Always consult the current official publication for clinical recommendations.

Official document